3-Fluoro-2-(hydroxymethyl)pyridine - CAS 31181-79-0
Catalog: |
BB020823 |
Product Name: |
3-Fluoro-2-(hydroxymethyl)pyridine |
CAS: |
31181-79-0 |
Synonyms: |
(3-fluoro-2-pyridinyl)methanol; (3-fluoropyridin-2-yl)methanol |
IUPAC Name: | (3-fluoropyridin-2-yl)methanol |
Description: | 3-Fluoro-2-(hydroxymethyl)pyridine (CAS# 31181-79-0) is a useful research chemical. |
Molecular Weight: | 127.12 |
Molecular Formula: | C6H6FNO |
Canonical SMILES: | C1=CC(=C(N=C1)CO)F |
InChI: | InChI=1S/C6H6FNO/c7-5-2-1-3-8-6(5)4-9/h1-3,9H,4H2 |
InChI Key: | FKTCIWBKNWUDAX-UHFFFAOYSA-N |
Boiling Point: | 194.287 °C at 760 mmHg |
Density: | 1.263 g/cm3 |
MDL: | MFCD09025826 |
LogP: | 0.71300 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021205311-A1 | Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors | 20200103 |
US-2021230294-A1 | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | 20200103 |
WO-2021138498-A1 | Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapy | 20200103 |
WO-2021138512-A1 | Combination therapy comprising a2a/a2b and pd-1/pd-l1 inhibitors | 20200103 |
CN-111004171-A | Novel synthesis method of 3-fluoropyridine-2-methanol | 20191218 |
Complexity: | 89.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 127.043341977 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 127.043341977 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 33.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS